MedAdvisor scores three-year Chemist Warehouse contract

MedAdvisor scores three-year Chemist Warehouse contract

Listed med-tech company MedAdvisor (ASX: MDR) has signed an agreement with one of Australia's leading pharmacies for three years.

Chemist Warehouse will partner with MedAdvisor for a period of three years and will see the pharmacy giant take advantage of MedAdvisor's PlusOne pharmacy software.

The two have already been working together for eight years, with MedAdvisor having provided Chemist Warehouse with its SMS services.

The new agreement will see Chemist Warehouse's retail pharmacies use PlusOne to drive more services to improve health outcomes for patients.

PlusOne is a platform for the delivery of 6CPA funded professional services for pharmacists, a Federal Government funded initiative that pays pharmacists for a range of health-related services to the community.

Chemist Warehouse will be able to invite, book, record and claim for 6CPA services delivered to customers using PlusOne.

The agreement with Chemist Warehouse is expected to deliver $5 million over the next three years for MedAdvisor.

"MedAdvisor is a truly agnostic player with a focus on developing the best software to help pharmacy link with patients and provide better health services," says MedAdvisor CEO Robert Read.

"As the largest pharmacy retailer in Australia and experts in execution Chemist Warehouse will drive improved health outcomes through the range of Health Programs available via MedAdvisor, which will be delivered both digitally and in-pharmacy."

The deal follows MedAdvisor's recently completed $17 million placement that was strongly supported by US healthcare solution provider HMS Holdings Corp who invested $11 million in the raise.

The funds are to go toward MedAdvisor's international expansion plans in the US, South East Asia and the UK, as well as driving domestic growth through sales, marketing and technology development.

Chemist Warehouse also recently expanded its partnership with Chinese B2C marketplace Tmall, operated by the Alibaba Group.

The deal extended Chemist Warehouse's agreement to sell via Tmall and included three new multi-brand stores: My Chemist, My Beauty Spot, and Discount Vitamin Warehouse.

Chemist Warehouse also announced that it would open a store on Alibaba-owned Lazada, the leading e-commerce platform in Southeast Asia, to reach consumers in Singapore and Malaysia.

Chemist Warehouse is the top-selling company on Tmall Global, offering more than 200 brands and over 3,200 stock keeping units.

Shares in MedAdvisor are up 1.89 per cent to $0.05 per share at 11.15am AEDT.

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

How communications technology can raise the bar on customer service, employee experience
Partner Content
From capturing feedback early to providing messages with a higher rate of cut-through, ...
Advertisement

Related Stories

Car subscription software company Loopit eyes global markets after $3.6m seed round

Car subscription software company Loopit eyes global markets after $3.6m seed round

In a bid to enter new global markets and capitalise on the growing ...

Fashion-tech startup Citizen Wolf uses data to tailor tees, alleviate landfill

Fashion-tech startup Citizen Wolf uses data to tailor tees, alleviate landfill

As a consequence of our addiction to fast fashion, Australia sends ...

Apollo to divest large share of motorhome fleet to get Tourism Holdings merger over the line

Apollo to divest large share of motorhome fleet to get Tourism Holdings merger over the line

In an effort to appease Australian and New Zealand regulator concer...

Dexus awards John Holland building contract in $2.1b Waterfront Brisbane project

Dexus awards John Holland building contract in $2.1b Waterfront Brisbane project

After securing an $830 million contract from Dexus (ASX: DXS), Melb...